Post-COVID cognitive dysfunction: current status and research recommendations for high risk population

被引:43
作者
Quan, Meina [1 ,2 ,3 ,4 ]
Wang, Xuechu [1 ,2 ]
Gong, Min [1 ,2 ]
Wang, Qi [1 ,2 ,3 ,4 ]
Li, Yan [1 ,2 ]
Jia, Jianping [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Innovat Ctr Neurol Disorders, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[3] Natl Ctr Neurol Disorders, Beijing, Peoples R China
[4] Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China
[5] Betjing Key Lab Geriatr Cognit Disorders, Beijing, Peoples R China
[6] Capital Med Univ, Clin Ctr Neurodegenerat Dis & Memory Impairment, Beijing, Peoples R China
[7] Capital Med Univ, Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Collaborat Innovat Ctr Brain Disorders, Beijing, Peoples R China
[8] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China
[9] Capital Med Univ, Xuanwu Hosp, Innovat Ctr Neurol Disorders, Beijing 100053, Peoples R China
[10] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing 100053, Peoples R China
来源
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2023年 / 38卷
基金
中国国家自然科学基金;
关键词
Long COVID; Post-COVID cognitive dysfunction; Epidemiology; Diagnosis; Risk factors; Management; ALZHEIMERS-DISEASE; HEALTH; METAANALYSIS; INFECTIONS; IMPAIRMENT; CARE;
D O I
10.1016/j.lanwpc.2023.100836
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Post-COVID cognitive dysfunction (PCCD) is a condition in which patients with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, usually three months from the onset, exhibit subsequent cognitive impairment in various cognitive domains, and cannot be explained by an alternative diagnosis. While our knowledge of the risk factors and management strategy of PCCD is still incomplete, it is necessary to integrate current epide-miology, diagnosis and treatment evidence, and form consensus criteria to better understand this disease to improve disease management. Identifying the risk factors and vulnerable population of PCCD and providing reliable stra-tegies for effective prevention and management is urgently needed. In this paper, we reviewed epidemiology, diagnostic markers, risk factors and available treatments on the disease, formed research recommendation frame-work for vulnerable population, under the background of post-COVID period.Copyright & COPY; 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in Malaysia
    Low, Ee Vien
    Pathmanathan, Mohan Dass
    Ten, Yi Yang
    Chidambaram, Suresh Kumar
    Kim, Wee Ric
    Lee, Wei Jia
    Teh, Zhi Wei
    Appannan, Maheshwara Rao
    Ismail, Mastura
    Samad, Azah Abdul
    Peariasamy, Kalaiarasu M.
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [42] Depression, Anxiety, and Neuropsychiatric Symptom Burden in a Longitudinal Cohort with Persistent Psychophysical Post-COVID Olfactory Dysfunction
    Saak, Tiana M.
    Tervo, Jeremy P.
    Vilarello, Brandon J.
    Jacobson, Patricia T.
    Caruana, Francesco F.
    Spence, Matthew D. A.
    Gallagher, Liam W.
    Gudis, David A.
    Motter, Jeffrey N.
    Devanand, Davangere P.
    Overdevest, Jonathan B.
    BRAIN SCIENCES, 2024, 14 (12)
  • [43] Prevalence and Risk Factors of De Novo Widespread Post-COVID Pain in Nonhospitalized COVID-19 Survivors: A Nationwide Exploratory Population-Based Survey
    Ebbesen, Brian D.
    Giordano, Rocco
    Valera-Calero, Juan Antonio
    Hedegaard, Jakob Nebeling
    Fernandez-de-las-Penas, Cesar
    Arendt-Nielsen, Lars
    JOURNAL OF PAIN, 2024, 25 (01) : 1 - 11
  • [44] Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up
    Granvik, Christoffer
    Andersson, Sara
    Andersson, Linus
    Brorsson, Camilla
    Forsell, Mattias
    Ahlm, Clas
    Normark, Johan
    Edin, Alicia
    BRAIN AND BEHAVIOR, 2024, 14 (06):
  • [45] Features of Mobile Apps for People with Autism in a Post COVID-19 Scenario: Current Status and Recommendations for Apps Using AI
    Rehman, Ikram Ur
    Sobnath, Drishty
    Nasralla, Moustafa M.
    Winnett, Maria
    Anwar, Aamir
    Asif, Waqar
    Sherazi, Hafiz Husnain Raza
    DIAGNOSTICS, 2021, 11 (10)
  • [46] Prevalence and risk factors for post-COVID conditions of COVID-19 among persons with HIV in Washington, DC
    Barth, Shannon
    Kulie, Paige
    Monroe, Anne
    Horberg, Michael
    Castel, Amanda
    Cohort, D. C.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2024, 36 (09): : 1358 - 1368
  • [47] Personality and behavioural outcomes in diving: current status and recommendations for future research
    Van Wijk, Charles H.
    DIVING AND HYPERBARIC MEDICINE, 2017, 47 (04) : 248 - 252
  • [48] RHEUMATOLOGICAL PAIN CONDITIONS ARE NOT RISK FACTORS FOR THE DEVELOPMENT OF WIDESPREAD POST-COVID PAIN IN COVID-19 SURVIVORS
    Arendt-Nielsen, L.
    Ebbesen, B. D.
    Giordano, R.
    Valera-Calero, J. A.
    Fernandez-de-Las-Penas, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1907 - 1907
  • [49] Cognitive behavioral therapy: Current status and future research directions
    Mcmain, Shelley
    Newman, Michelle G.
    Segal, Zindel V.
    DeRubeis, Robert J.
    PSYCHOTHERAPY RESEARCH, 2015, 25 (03) : 321 - 329
  • [50] The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations
    Nosheny, Rachel L.
    Amariglio, Rebecca
    Sikkes, Sietske A. M.
    Van Hulle, Carol
    Camargos Bicalho, Maria Aparecida
    Dowling, N. Maritza
    Dozzi Brucki, Sonia Maria
    Ismail, Zahinoor
    Kasuga, Kensaku
    Kuhn, Elizabeth
    Numbers, Katya
    Aaronson, Anna
    Moretti, Davide Vito
    Pereiro, Arturo X.
    Sanchez-Benavides, Gonzalo
    Sellek Rodriguez, Allis F.
    Urwyler, Prabitha
    Zawaly, Kristina
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)